Infant Bacterial Therapeutics AB (IFTBF)
6.85
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Infant Bacterial Therapeutics EPS Diluted (Quarterly) : -0.2357 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2357 |
| March 31, 2026 | -0.1863 |
| December 31, 2025 | -0.1515 |
| September 30, 2025 | -0.0784 |
| June 30, 2025 | -0.1472 |
| March 31, 2025 | -0.1164 |
| December 31, 2024 | -0.2325 |
| September 30, 2024 | -0.2325 |
| June 30, 2024 | -0.2963 |
| March 31, 2024 | -0.1986 |
| December 31, 2023 | -0.2845 |
| September 30, 2023 | -0.2136 |
| June 30, 2023 | -0.2437 |
| March 31, 2023 | -0.1917 |
| December 31, 2022 | -0.333 |
| September 30, 2022 | -0.0657 |
| June 30, 2022 | 0.0149 |
| March 31, 2022 | -0.1831 |
| December 31, 2021 | -0.163 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.0006 |
| June 30, 2021 | -0.3085 |
| March 31, 2021 | 0.0048 |
| December 31, 2020 | -0.2764 |
| September 30, 2020 | -0.1867 |
| June 30, 2020 | -0.2569 |
| March 31, 2020 | 0.0108 |
| December 31, 2019 | -0.255 |
| September 30, 2019 | -0.0979 |
| June 30, 2019 | -0.0713 |
| March 31, 2019 | -0.0067 |
| December 31, 2018 | -0.2378 |
| September 30, 2018 | -0.0795 |
| June 30, 2018 | 0.0068 |
| March 31, 2018 | -0.1183 |
| December 31, 2017 | -0.1657 |
| September 30, 2017 | -0.0912 |
| June 30, 2017 | -0.2552 |
| March 31, 2017 | -0.1565 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -0.3052 |
| Swedencare AB | 0.0158 |
| Camurus AB | 0.432 |
| Moberg Pharma AB | -0.0075 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.175M |
| Total Expenses (Quarterly) | 3.175M |
| Enterprise Value | 81.06M |
| Earnings Yield | -9.52% |
| Normalized Earnings Yield | -9.515 |